2012
DOI: 10.1186/1546-0096-10-s1-a95
|View full text |Cite
|
Sign up to set email alerts
|

Tocilizumab for refractory Castleman’s disease with paraneoplastic pemphigus and Behçet’s disease

Abstract: From 2011 Pediatric Rheumatology Symposium sponsored by the American College of Rheumatology Miami, FL, USA. 2-5 June 2011Purpose Castleman's disease (CD) is an uncommon lymphoproliferative disorder, eventually complicated with paraneoplastic pemphigus (PNP) and pulmonary involvement. The association of Behçet and CD is very rare and the outcome is worse when PNP is present. MethodsWe describe a 17 yo female patient with Behçet's syndrome and CD. She was affected by a 4-month history of severe oral and genital… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Behcet’s disease may predispose patients to develop subcutaneous emphysema. While more data are needed to determine whether a causal relationship exists, this is an observation based on ours and two previously reported cases [ 2 , 3 ].…”
mentioning
confidence: 54%
“…Behcet’s disease may predispose patients to develop subcutaneous emphysema. While more data are needed to determine whether a causal relationship exists, this is an observation based on ours and two previously reported cases [ 2 , 3 ].…”
mentioning
confidence: 54%
“…The presence of BD with CD is quite rare, as only a few cases have been reported worldwide. Reported cases include young patients who were diagnosed with BD prior to the diagnosis of CD and one case associated with the relapsed phase of the disease years after receiving the treatment of CD [2][3]. None of the reported cases had a similar finding of the incidental chronic pulmonary aneurysm as a leading sign to diagnose BD, as only 25% to 30% of patients with BD will have vascular involvement, 10% to 15% of which account for arterial involvement [4].…”
Section: Discussionmentioning
confidence: 99%